Quidel Q4, Full-Year 2017 Revenues Spike on Triage Acquisition
Mar 2, 2018 @ 14:08

The increased revenues were due primarily to cardiac immunoassay sales from the newly acquired Triage and BNP businesses as well as increased sales of rapid immunoassay products.

Sourced through Scoop.it from: www.genomeweb.com

Leave a Reply